Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study
High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. T...
Saved in:
| Published in | BMC medicine Vol. 21; no. 1; pp. 461 - 17 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
23.11.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter.
From June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator's discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24-72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test.
All enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA
DS
-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743).
Involving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter.
Clinicaltrials.gov: NCT04408716. AF = Atrial fibrillation, DWI = Diffusion-weighted magnetic resonance imaging, HPSD = High-power short-duration, ST = Smart Touch, STSF = Smart Touch Surround Flow. |
|---|---|
| AbstractList | High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter.BACKGROUNDHigh-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter.From June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator's discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24-72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test.METHODSFrom June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator's discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24-72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test.All enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA2DS2-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743).RESULTSAll enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA2DS2-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743).Involving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter.CONCLUSIONSInvolving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter.Clinicaltrials.gov: NCT04408716. AF = Atrial fibrillation, DWI = Diffusion-weighted magnetic resonance imaging, HPSD = High-power short-duration, ST = Smart Touch, STSF = Smart Touch Surround Flow.TRIAL REGISTRATIONClinicaltrials.gov: NCT04408716. AF = Atrial fibrillation, DWI = Diffusion-weighted magnetic resonance imaging, HPSD = High-power short-duration, ST = Smart Touch, STSF = Smart Touch Surround Flow. Background High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter. Methods From June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator's discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24-72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test. Results All enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA.sub.2DS.sub.2-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743). Conclusions Involving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter. Trial registration Clinicaltrials.gov: NCT04408716. Graphical AF = Atrial fibrillation, DWI = Diffusion-weighted magnetic resonance imaging, HPSD = High-power short-duration, ST = Smart Touch, STSF = Smart Touch Surround Flow. Keywords: Atrial fibrillation, Catheter ablation, High-power short-duration, Silent cerebral embolism, High-resolution diffusion-weighted magnetic resonance imaging High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter. From June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator's discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24-72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test. All enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA.sub.2DS.sub.2-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743). Involving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter. High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter. From June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator's discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24-72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test. All enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA DS -VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743). Involving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter. Clinicaltrials.gov: NCT04408716. AF = Atrial fibrillation, DWI = Diffusion-weighted magnetic resonance imaging, HPSD = High-power short-duration, ST = Smart Touch, STSF = Smart Touch Surround Flow. BackgroundHigh-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter.MethodsFrom June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator’s discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24–72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test.ResultsAll enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA2DS2-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743).ConclusionsInvolving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter.Trial registrationClinicaltrials.gov: NCT04408716. Abstract Background High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The utilized Smart Touch Surround Flow (STSF) catheter, with 56 holes around the electrode, lowers electrode-tissue temperature and thrombus risk. Thus, we conducted this prospective, randomized study to investigate if the HPSD strategy with STSF catheter in AF ablation procedures reduces the silent cerebral embolism (SCE) risk compared to the conventional approach with the Smart Touch (ST) catheter. Methods From June 2020 to September 2021, 100 AF patients were randomized 1:1 to the HPSD group using the STSF catheter (power set at 50 W) or the conventional group using the ST catheter (power set at 30 to 35 W). Pulmonary vein isolation was performed in all patients, with additional lesions at operator’s discretion. High-resolution cerebral diffusion-weighted magnetic resonance imaging (hDWI) with slice thickness of 1 mm was performed before and 24–72 h after ablation. The incidence of new periprocedural SCE was defined as the primary outcome. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) test. Results All enrolled AF patients (median age 63, 60% male, 59% paroxysmal AF) underwent successful ablation. Post-procedural hDWI identified 106 lesions in 42 enrolled patients (42%), with 55 lesions in 22 patients (44%) in the HPSD group and 51 lesions in 20 patients (40%) in the conventional group (p = 0.685). No significant differences were observed between two groups regarding the average number of lesions (p = 0.751), maximum lesion diameter (p = 0.405), and total lesion volume per patient (p = 0.669). Persistent AF and CHA2DS2-VASc score were identified as SCE determinants during AF ablation procedure by multivariable regression analysis. No significant differences in MoCA scores were observed between patients with SCE and those without, both immediately post-procedure (p = 0.572) and at the 3-month follow-up (p = 0.743). Conclusions Involving a small sample size of 100 AF patients, this study reveals a similar incidence of SCE in AF ablation procedures, comparing the HPSD strategy using the STSF catheter to the conventional approach with the ST catheter. Trial registration Clinicaltrials.gov: NCT04408716. Graphical Abstract AF = Atrial fibrillation, DWI = Diffusion-weighted magnetic resonance imaging, HPSD = High-power short-duration, ST = Smart Touch, STSF = Smart Touch Surround Flow. |
| ArticleNumber | 461 |
| Audience | Academic |
| Author | Ling, Zhi-Yu Xiong, Qing-Song Tao, Xie-Xin Li, Ran Zou, Li-Li Chen, Wei-Jie Liu, Zeng-Zhang Gan, Chun-Xia Liu, Yang-Yang Du, Hua-An Qin, Fang Yin, Yue-Hui Xiao, Pei-Lin Cai, Yang-Wei |
| Author_xml | – sequence: 1 givenname: Wei-Jie surname: Chen fullname: Chen, Wei-Jie – sequence: 2 givenname: Chun-Xia surname: Gan fullname: Gan, Chun-Xia – sequence: 3 givenname: Yang-Wei surname: Cai fullname: Cai, Yang-Wei – sequence: 4 givenname: Yang-Yang surname: Liu fullname: Liu, Yang-Yang – sequence: 5 givenname: Pei-Lin surname: Xiao fullname: Xiao, Pei-Lin – sequence: 6 givenname: Li-Li surname: Zou fullname: Zou, Li-Li – sequence: 7 givenname: Qing-Song surname: Xiong fullname: Xiong, Qing-Song – sequence: 8 givenname: Fang surname: Qin fullname: Qin, Fang – sequence: 9 givenname: Xie-Xin surname: Tao fullname: Tao, Xie-Xin – sequence: 10 givenname: Ran surname: Li fullname: Li, Ran – sequence: 11 givenname: Hua-An surname: Du fullname: Du, Hua-An – sequence: 12 givenname: Zeng-Zhang surname: Liu fullname: Liu, Zeng-Zhang – sequence: 13 givenname: Yue-Hui surname: Yin fullname: Yin, Yue-Hui – sequence: 14 givenname: Zhi-Yu surname: Ling fullname: Ling, Zhi-Yu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37996906$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UttqFTEUHaRiL_oDPkhAEF-m5jKZzPhWipcDBV_0OWSSnTMpmckxyVTq5_il5lyqbREJITthrZV9WafV0RxmqKqXBJ8T0rXvEqE9aWtMWY0Z6XDNnlQnRDSkFpjwo3vxcXWa0jXGlAvRPKuOmej7tsftSfVrNW2UzihYNLr1WG_CD4gojSHm2ixRZRdmpHJ0yiPrhui8P7wNhyCDHmf3fQG0vYyA3KydgVnDVjQ5D3NGGiIMsWjANATv0vQeKbSJIW1AZ3cDKKrZhMn9BIN0mHMM3pcw5cXcPq-eWuUTvDicZ9W3jx--Xn6ur758Wl1eXNWasz7Xthk4NxaDEcDAdg0eMOmt4IQpMUDLaYOJYVgRRomyvbV46Hk7tFg0oLBhZ9Vqr2uCupab6CYVb2VQTu4eQlxLFbPTHqQRneGd5j0RtqgOiivcaNFyMLRrRVe03u61So2lNSnLySUNpXkzhCVJ2vWsYw2nbYG-fgS9DkucS6WS9pgSSsv-i1qr8r-bbchR6a2ovCgzxYQx3hfU-T9QZRmYXOkr2DKOh4Q39wgjKJ_HFPyynWx6CHx1yHIZJjB_2nPnpALo9gBdppoiWKld3jmkpOC8JFhuTSv3ppXFtHJnWskKlT6i3qn_h_QbpEbueg |
| CitedBy_id | crossref_primary_10_1016_j_hrthm_2024_05_048 crossref_primary_10_1093_eurheartj_ehae618 crossref_primary_10_1111_jce_16337 crossref_primary_10_22141_2224_0586_20_3_2024_1688 crossref_primary_10_1038_s41569_024_01076_0 crossref_primary_10_1016_j_hroo_2024_09_019 |
| Cites_doi | 10.1007/s10840-019-00645-5 10.1111/jce.13227 10.1016/j.hrthm.2011.06.030 10.1093/europace/eux274 10.1111/j.1540-8167.1999.tb00706.x 10.1111/jce.14223 10.1111/j.1540-8167.2012.02298.x 10.1093/eurheartj/ehac020 10.1093/europace/euab329 10.1016/j.hrthm.2020.03.022 10.1053/eupc.2001.0167 10.1016/j.hrthm.2020.05.029 10.3389/fcvm.2021.777355 10.1016/j.ijcard.2004.03.010 10.1111/j.1540-8167.2011.02050.x 10.1002/joa3.12590 10.1111/jce.14800 10.1016/j.jacep.2022.12.020 10.1016/j.jacc.2009.11.040 10.1093/europace/euaa144 10.1111/jce.14868 10.1007/s00380-017-0985-4 10.1161/CIRCEP.112.971747 10.1161/CIRCEP.119.007548 10.1111/jce.12221 10.1016/j.hrthm.2014.03.003 10.1016/j.jacc.2018.12.039 10.1016/j.jacep.2020.04.023 10.1253/circj.CJ-15-1368 10.1093/europace/euy148 10.1093/eurheartj/ehaa612 10.1161/CIR.0000000000000665 10.1093/europace/euy224 10.1016/j.mri.2012.05.001 10.1111/jce.12608 10.1093/ehjci/jev304 10.1016/j.hrthm.2018.11.031 10.1111/jce.15504 10.1016/j.jacc.2013.05.074 10.1016/j.pcad.2015.08.004 10.1111/jce.13813 10.1111/jce.14219 10.1111/j.1540-8167.2012.02420.x |
| ContentType | Journal Article |
| Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 DOA |
| DOI | 10.1186/s12916-023-03180-3 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1741-7015 |
| EndPage | 17 |
| ExternalDocumentID | oai_doaj_org_article_d78d58c5917f401ba5a04c765ed28678 A774013359 37996906 10_1186_s12916_023_03180_3 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: Program for Youth Innovation in Future Medicine, Chongqing Medical University grantid: W0112 – fundername: Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University grantid: kryc-yq-2103 – fundername: Natural Science Foundation Project of Chongqing grantid: cstc2021jcyj-msxmX0075 – fundername: Program for Youth Innovation in Future Medicine, Chongqing Medical University grantid: W0078 |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 PUEGO |
| ID | FETCH-LOGICAL-c539t-f4b55df0ed7e3ef840b019f7513a7be652401d30a1321af9ff0b956b6074ea0d3 |
| IEDL.DBID | M48 |
| ISSN | 1741-7015 |
| IngestDate | Wed Aug 27 01:31:40 EDT 2025 Fri Jul 11 09:37:43 EDT 2025 Sat Jul 26 00:29:10 EDT 2025 Tue Jun 17 22:25:05 EDT 2025 Tue Jun 10 21:19:21 EDT 2025 Thu May 22 21:12:29 EDT 2025 Mon Jul 21 05:16:07 EDT 2025 Tue Jul 01 02:51:37 EDT 2025 Thu Apr 24 23:01:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | High-resolution diffusion-weighted magnetic resonance imaging High-power short-duration Atrial fibrillation Catheter ablation Silent cerebral embolism |
| Language | English |
| License | 2023. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c539t-f4b55df0ed7e3ef840b019f7513a7be652401d30a1321af9ff0b956b6074ea0d3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12916-023-03180-3 |
| PMID | 37996906 |
| PQID | 2902122212 |
| PQPubID | 42775 |
| PageCount | 17 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d78d58c5917f401ba5a04c765ed28678 proquest_miscellaneous_2893834526 proquest_journals_2902122212 gale_infotracmisc_A774013359 gale_infotracacademiconefile_A774013359 gale_healthsolutions_A774013359 pubmed_primary_37996906 crossref_citationtrail_10_1186_s12916_023_03180_3 crossref_primary_10_1186_s12916_023_03180_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-11-23 |
| PublicationDateYYYYMMDD | 2023-11-23 |
| PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-23 day: 23 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC medicine |
| PublicationTitleAlternate | BMC Med |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | F Gaita (3180_CR44) 2013; 62 S Chen (3180_CR9) 2019; 30 E Nagy-Baló (3180_CR41) 2013; 6 DG Shin (3180_CR12) 2020; 22 S Castrejón-Castrejón (3180_CR14) 2020; 57 S Chen (3180_CR21) 2020; 17 T Deneke (3180_CR42) 2011; 8 D Conen (3180_CR6) 2019; 73 L Di Biase (3180_CR29) 2014; 11 SJ Dikdan (3180_CR22) 2021; 32 M Kühne (3180_CR5) 2022; 43 H Calkins (3180_CR26) 2018; 20 M Scaglione (3180_CR24) 2012; 23 K Nakamura (3180_CR30) 2016; 80 J Müller (3180_CR16) 2022; 24 RA Winkle (3180_CR23) 2020; 17 S Prabhu (3180_CR36) 2015; 58 G Stabile (3180_CR18) 2017; 28 HD Yavin (3180_CR10) 2020; 6 A Fedorov (3180_CR19) 2012; 30 D Lee (3180_CR40) 2001; 3 C-I Park (3180_CR17) 2013; 24 J Müller (3180_CR15) 2022; 33 T Deneke (3180_CR3) 2015; 26 F Gaita (3180_CR39) 2011; 22 AC Lee (3180_CR25) 2023; 9 B Wożakowska-Kapłon (3180_CR35) 2005; 101 K Nakamura (3180_CR31) 2021; 32 T Nagao (3180_CR27) 2019; 21 G Hindricks (3180_CR1) 2021; 42 RA Winkle (3180_CR7) 2019; 16 DC Lee (3180_CR37) 2016; 17 3180_CR20 KG Haeusler (3180_CR43) 2013; 24 CT January (3180_CR2) 2019; 140 J Zheng (3180_CR33) 2021; 8 OG Anfinsen (3180_CR38) 1999; 10 A Doi (3180_CR32) 2017; 32 CB de Vos (3180_CR34) 2010; 55 H Okamatsu (3180_CR11) 2019; 30 Y Waranugraha (3180_CR13) 2021; 37 K Nakamura (3180_CR28) 2019; 21 G Dhillon (3180_CR8) 2019; 30 Y Yu (3180_CR4) 2020; 13 |
| References_xml | – volume: 57 start-page: 57 year: 2020 ident: 3180_CR14 publication-title: J Interv Card Electrophysiol doi: 10.1007/s10840-019-00645-5 – volume: 28 start-page: 762 year: 2017 ident: 3180_CR18 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.13227 – volume: 8 start-page: 1705 year: 2011 ident: 3180_CR42 publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2011.06.030 – volume: 20 start-page: e1 year: 2018 ident: 3180_CR26 publication-title: Europace doi: 10.1093/europace/eux274 – volume: 10 start-page: 503 year: 1999 ident: 3180_CR38 publication-title: J Cardiovasc Electrophysiol. doi: 10.1111/j.1540-8167.1999.tb00706.x – volume: 30 start-page: 2751 year: 2019 ident: 3180_CR11 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.14223 – volume: 23 start-page: 801 year: 2012 ident: 3180_CR24 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2012.02298.x – volume: 43 start-page: 2127 year: 2022 ident: 3180_CR5 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehac020 – volume: 24 start-page: 928 year: 2022 ident: 3180_CR16 publication-title: EP Europace doi: 10.1093/europace/euab329 – volume: 17 start-page: 1223 year: 2020 ident: 3180_CR23 publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2020.03.022 – volume: 3 start-page: 195 year: 2001 ident: 3180_CR40 publication-title: Europace doi: 10.1053/eupc.2001.0167 – volume: 17 start-page: 1833 year: 2020 ident: 3180_CR21 publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2020.05.029 – volume: 8 start-page: 777355 year: 2021 ident: 3180_CR33 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2021.777355 – ident: 3180_CR20 – volume: 101 start-page: 47 year: 2005 ident: 3180_CR35 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2004.03.010 – volume: 22 start-page: 961 year: 2011 ident: 3180_CR39 publication-title: J Cardiovasc Electrophysiol. doi: 10.1111/j.1540-8167.2011.02050.x – volume: 37 start-page: 975 year: 2021 ident: 3180_CR13 publication-title: J Arrhythmia doi: 10.1002/joa3.12590 – volume: 32 start-page: 16 year: 2021 ident: 3180_CR31 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.14800 – volume: 9 start-page: 1038 year: 2023 ident: 3180_CR25 publication-title: JACC Clin Electrophysiol doi: 10.1016/j.jacep.2022.12.020 – volume: 55 start-page: 725 year: 2010 ident: 3180_CR34 publication-title: J Am Coll Cardiol. doi: 10.1016/j.jacc.2009.11.040 – volume: 22 start-page: 1495 year: 2020 ident: 3180_CR12 publication-title: Europace doi: 10.1093/europace/euaa144 – volume: 32 start-page: 608 year: 2021 ident: 3180_CR22 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.14868 – volume: 32 start-page: 1227 year: 2017 ident: 3180_CR32 publication-title: Heart Vessels doi: 10.1007/s00380-017-0985-4 – volume: 6 start-page: 473 year: 2013 ident: 3180_CR41 publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.112.971747 – volume: 13 start-page: e007548 year: 2020 ident: 3180_CR4 publication-title: Circ Arrhythmia Electrophysiol doi: 10.1161/CIRCEP.119.007548 – volume: 24 start-page: 1328 year: 2013 ident: 3180_CR17 publication-title: J Cardiovasc Electrophysiol. doi: 10.1111/jce.12221 – volume: 11 start-page: 791 year: 2014 ident: 3180_CR29 publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2014.03.003 – volume: 73 start-page: 989 year: 2019 ident: 3180_CR6 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.12.039 – volume: 6 start-page: 973 year: 2020 ident: 3180_CR10 publication-title: JACC Clin Electrophysiol doi: 10.1016/j.jacep.2020.04.023 – volume: 80 start-page: 870 year: 2016 ident: 3180_CR30 publication-title: Circ J doi: 10.1253/circj.CJ-15-1368 – volume: 21 start-page: 259 year: 2019 ident: 3180_CR28 publication-title: Europace doi: 10.1093/europace/euy148 – volume: 42 start-page: 373 year: 2021 ident: 3180_CR1 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa612 – volume: 140 start-page: e125 year: 2019 ident: 3180_CR2 publication-title: Circulation doi: 10.1161/CIR.0000000000000665 – volume: 21 start-page: 590 year: 2019 ident: 3180_CR27 publication-title: Europace doi: 10.1093/europace/euy224 – volume: 30 start-page: 1323 year: 2012 ident: 3180_CR19 publication-title: Magn Reson Imaging doi: 10.1016/j.mri.2012.05.001 – volume: 26 start-page: 455 year: 2015 ident: 3180_CR3 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.12608 – volume: 17 start-page: 1259 year: 2016 ident: 3180_CR37 publication-title: Eur Heart J Cardiovasc Imaging doi: 10.1093/ehjci/jev304 – volume: 16 start-page: 165 year: 2019 ident: 3180_CR7 publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2018.11.031 – volume: 33 start-page: 1425 year: 2022 ident: 3180_CR15 publication-title: Cardiovasc electrophysiol doi: 10.1111/jce.15504 – volume: 62 start-page: 1990 year: 2013 ident: 3180_CR44 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.05.074 – volume: 58 start-page: 152 year: 2015 ident: 3180_CR36 publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2015.08.004 – volume: 30 start-page: 357 year: 2019 ident: 3180_CR8 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.13813 – volume: 30 start-page: 2724 year: 2019 ident: 3180_CR9 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.14219 – volume: 24 start-page: 14 year: 2013 ident: 3180_CR43 publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2012.02420.x |
| SSID | ssj0025774 |
| Score | 2.4247878 |
| Snippet | High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation time. The... Background High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation... BackgroundHigh-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter ablation... Abstract Background High-power short-duration (HPSD) ablation strategy has emerged as a popular approach for treating atrial fibrillation (AF), with shorter... |
| SourceID | doaj proquest gale pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 461 |
| SubjectTerms | Ablation Ablation Techniques - adverse effects Analysis Anticoagulants Atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - epidemiology Atrial Fibrillation - surgery Blood clots Cardiac arrhythmia Care and treatment Catheter ablation Catheter Ablation - adverse effects Catheter Ablation - methods Catheters Cognitive ability Consent Contraindications Diagnosis Diameters Electrodes Embolism Embolisms Energy Female Fibrillation High-power short-duration High-resolution diffusion-weighted magnetic resonance imaging Humans Incidence Intracranial Embolism - diagnostic imaging Intracranial Embolism - epidemiology Intracranial Embolism - prevention & control Lesions Magnetic resonance imaging Male Medical instruments Middle Aged Prevention Prospective Studies Radio frequency Recurrence Regression analysis Risk factors Silent cerebral embolism Strategy Thrombosis Treatment Outcome Veins & arteries |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gL4ptAASMhcUBR4zi2Y24FURWkcqJSb5Yd2-pK2U3V7F74Of2lnXGciAUJLhxWyiaTVeIZz8xbe94Q8k5VXtQ2srLmWpZIcV5qxUKJKz62RcwhsVD47Ls8PW--XYiLX1p94Z6wiR54Grgjr1ov2k4ArIiABZwVtmo6JUXwdQueFr0vxLwZTGWoJSCrmUtkWnk0QlRjuNmWl2jE4Hn2wlBi6__TJ_-WaaaIc_KA3M-pIj2eHvEhuRM2j8jds7wY_pjcfE0VjnSIFEmHyytseEbHS0ioS7-bNEttastBI-7s7_t8zuWDhcCV4pfLQPGP99RkFH90XGFEol24xsXlnoa1G_rVuP5ILYWHn2s0KUQ7P6xXP4OneeN7D4eJt_YJOT_58uPzaZlbLpSd4HpbxsYJ4WMVvAo8REB_DnLAqATjVrkgBSQAzPPKAohlNuoYKwcIy0nIRIKtPH9KDjbDJjwnVKpOeamj8Jo3PDJto1e-Y6F2TeRNVRA2a8B0mY8c22L0JuGSVppJawa0ZpLWDC_Ih-Weq4mN46_Sn1CxiyQyaacTYF8m25f5l30V5A2ahZnKUhd_YI5V6mXIhS7I-ySBHgFeoLO5sAGGAbm19iQP9yRhJnf7l2fTM9mTjKbWSMJfw6cgb5fLeCfujtuEYQcykHS2HJvFF-TZZLLLS3MFiFZX8sX_GIyX5F6Nk4jh3D4kB9vrXXgFSdnWvU7z7xZD9jIH priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4t2UAkZC4oCsJnFsJ1xQQVQFqZyotDfLjm26UnazbHYv_Jz-UmYcb6oFqYdIeUyi9c54HvbMN4S8U7kTpQkFK3kjGUKcs0YVnuGOj6kx5pBYKHzxQ55fVt9nYpYW3IaUVrnTiVFRu77FNfKTskEw8hKOT6vfDLtG4e5qaqFxl9xD6DKUajW7CbgE-Da7Qplangxg2wpMueUMRRn0z54xipj9_2vmf_zNaHfOHpGHyWGkpyOHH5M7fvmE3L9IW-JPyfW3WOdI-0ARepitsO0ZHa7ArWZuO_KXmticgwbM7--6dM-mkwnGleLFlae4_B5bjeJHhznaJdr6NW4xd9QvbN_Nh8VHaij8-F2lJgWb5_rF_I93NKW_d3Aa0Wufkcuzrz-_nLPUeIG1gjcbFiorhAu5d8pzHyAGtOAJBiUKbpT1UoAbUDieGwhlCxOaEHILcZaV4I94kzv-nBws-6U_JFSqVjnZBOEaXvFQNCY45drCl7YKvMozUuw4oNuESo7NMTodo5Na6pFrGrimI9c0z8iH6Z3ViMlxK_VnZOxEiXja8Ua__qXT9NRO1U7UrYDgNcDYrBEmr1olhXdlDfY8I29QLPRYnDppBX2qYkdDLpqMvI8UqBdgAK1J5Q3wNyDC1h7l8R4lzOd2__FO9HTSJ4O-kf6MvJ0e45uYI7f0_RZowPWsObaMz8iLUWSnQXMFcW2Ty6PbP_6SPChxehQ4d4_JwWa99a_A6drY13Fm_QUIhint priority: 102 providerName: ProQuest |
| Title | Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37996906 https://www.proquest.com/docview/2902122212 https://www.proquest.com/docview/2893834526 https://doaj.org/article/d78d58c5917f401ba5a04c765ed28678 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ri9QwEA_3APGL-L7quUYQ_CDVpmmSVhC5lTtOYQ85XDj8EtIm8Ra623MfoP45_qXOpA9YPcQPLX1MStOZycw0md8Q8lwlVqTGszjlhYwR4jwuFHMxzviYHGMOiYnCkzN5Os0-XoiLHdKXO-o-4Ora0A7rSU2X9avv3368A4V_GxQ-l69XYLMYLqXlMYoojCu7ZB8sk8KKBpNsmFUA6QyozOCEs1iBHeyTaK59xpahCnj-f4_af_iiwSad3Ca3OmeSHrXcv0N23OIuuTHppsvvkV8fQg4kbTxFWOL4Ckui0dUl9Da2m5b31ITCHdTj2v-67q6V3cEA8Urx5NJR_DUfypDiQ1cztFm0ckucfq6pm5dNPVvN31BD4eX7LE4K9tA289lPZ2m3NL6Gw4Bse59MT44_vz-Nu6IMcSV4sY59VgphfeKsctx5iA9L8BK9EowbVTopwEVglicGwlxmfOF9UkIMVkrwVZxJLH9A9hbNwh0QKlWlrCy8sAXPuGeF8VbZirm0zDzPkoiwngO66hDLsXBGrUPkkkvdck0D13TgmuYReTm0uWrxOv5JPUbGDpSItR0uNMuvulNdbVVuRV4JCGw99K00wiRZpaRwNs3B1kfkKYqFbhNXhxFDH6lQ7ZCLIiIvAgVKMXSgMl3qA3wGRN_aojzcogRdr7Zv96Kne1XRaYEw_SlsEXk23MaWuH5u4ZoN0IBbmnMsJx-Rh63IDp3mCmLeIpGP_qP1Y3IzRR1hqNyHZG-93Lgn4JWtyxHZVRdqRPbHx2efzkfh38YoqB_sz8dffgPxiTWi |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2gUCOBOKCoSRzbCRJC5VHt0m5PrdSbcWKbrpTdLJtdIfg5_AB-IzPOo1qQeushUh4Ta73z_GLPDCEvZWR4ol0cJiwXIZY4D3MZ2xBXfHSGmENgovDkWIxO0y9n_GyL_OlzYXBbZW8TvaE2dYnfyPeSHIuRJ3C8X3wPsWsUrq72LTRasTi0P38AZGvejT8Bf18lycHnk4-jsOsqEJac5avQpQXnxkXWSMusA4BTQJjjJI-ZloUVHHxcbFikAafF2uXORQWAiEKAs7U6MgzGvUaug-ONEOzJswuAxyGW6hNzMrHXgC-NcYsvC1F1wN5tOD_fI-B_T_BPfOv93MEdcrsLUOl-K1F3yZad3yM3Jt0S_H3ye-zzKmntKJY6DhfYZo025xDGh2bdyhPVvhkIdZhPUFXdvaI7GcrGUrw4txQ_9_vWpjhoM0U_SEu7xCXtitpZUVfTZvaWago_vs8MpeBjTT2b_rKGdtvtKzj11XIfkNMrYclDsj2v5_YxoUKW0ojccZOzlLk4185IU8Y2KVLH0iggcc8BVXZV0LEZR6U8GsqEarmmgGvKc02xgLwZ3lm0NUAupf6AjB0osX63v1Evv6nOHCgjM8OzkgNYdjC3QnMdpaUU3Jokg_ghILsoFqpNhh2skNqXvoMi43lAXnsKtEMwgVJ36RTwN2BFrw3KnQ1KsB_l5uNe9FRnvxp1oW0BeTE8xjdxT97c1muggVA3Y9iiPiCPWpEdJs0k4Og8Ek8uH3yX3BydTI7U0fj48Cm5laCqxGg3dsj2arm2zyDgWxXPvZZR8vWq1fov5VZmzA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+high-power+short-duration+atrial+fibrillation+ablation+technique+on+the+incidence+of+silent+cerebral+embolism%3A+a+prospective+randomized+controlled+study&rft.jtitle=BMC+medicine&rft.au=Chen%2C+Wei-Jie&rft.au=Gan%2C+Chun-Xia&rft.au=Cai%2C+Yang-Wei&rft.au=Liu%2C+Yang-Yang&rft.date=2023-11-23&rft.issn=1741-7015&rft.eissn=1741-7015&rft.volume=21&rft.issue=1&rft.spage=461&rft_id=info:doi/10.1186%2Fs12916-023-03180-3&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon |